» Articles » PMID: 6588195

Self-association of Doxorubicin and Related Compounds in Aqueous Solution

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 1984 Jun 1
PMID 6588195
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The dimerization of doxorubicin, daunorubicin, and their 4-demethoxy, 4'-epi, and 4'-deoxy analogues was studied spectrophotometrically. Self-association was found to be influenced by buffer composition and ionic strength. Kd values were 1.3 X 10(4) and 2.3 X 10(4) M-1 for doxorubicin and daunorubicin, respectively, and ranged from 3.8 X 10(3) to 6.1 X 10(3) M-1 for the 4-demethoxy analogues. For 4'-epi- and 4'-deoxydoxorubicin, tetramerization has also been considered. On this basis, values of 2.0 X 10(4) and 2.2 X 10(4) M-1 were found, respectively, for the formation constant of the dimerization process. Stability of the dimeric species appears to be strongly influenced by substitution of the chromophore moiety.

Citing Articles

Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells.

Degerstedt O, OCallaghan P, Lerma Clavero A, Grasjo J, Eriksson O, Sjogren E Drug Deliv Transl Res. 2023; 14(4):970-983.

PMID: 37824040 PMC: 10927899. DOI: 10.1007/s13346-023-01445-1.


Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia.

Ma W, Rousseau Z, Slavkovic S, Shen C, Yousef G, Ni H Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558895 PMC: 9788583. DOI: 10.3390/ph15121444.


Doxorubicin aqueous systems at low concentrations: Interconnection between self-organization, fluorescent and physicochemical properties, and action on hydrobionts.

Ryzhkina I, Murtazina L, Kostina L, Dokuchaeva I, Sergeeva S, Meleshenko K Front Chem. 2022; 10:1063278.

PMID: 36531320 PMC: 9751371. DOI: 10.3389/fchem.2022.1063278.


Chitosan-Boric Acid Scaffolds for Doxorubicin Delivery in the Osteosarcoma Treatment.

Dornjak L, Kovacic M, Ostojic K, Angaits A, Szpunar J, Urlic I Polymers (Basel). 2022; 14(21).

PMID: 36365746 PMC: 9656110. DOI: 10.3390/polym14214753.


Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.

Eljack S, David S, Faggad A, Chourpa I, Allard-Vannier E Int J Pharm X. 2022; 4:100126.

PMID: 36147518 PMC: 9486027. DOI: 10.1016/j.ijpx.2022.100126.